MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer.

CONCLUSION: MiR-128 might be a prognostic marker and possible molecular target for therapy in patients with TNBC. PMID: 29116653 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29116653?dopt=Abstract

Source: The British Journal of Surgery - November 8, 2017 Category: Surgery Authors: Xiao M, Lou C, Xiao H, Yang Y, Cai X, Li C, Jia S, Huang Y Tags: Br J Surg Source Type: research